{
  "url": "https://openlegislation.uk/medicines-products-for-animal-use-fees-regulations-1995/schedule-1/paragraph-5",
  "json_url": "https://openlegislation.uk/medicines-products-for-animal-use-fees-regulations-1995/schedule-1/paragraph-5.json",
  "legislation": "uksi/1995/2364",
  "legislation_title": "The Medicines (Products for Animal Use — Fees) Regulations 1995",
  "legislation_url": "https://openlegislation.uk/medicines-products-for-animal-use-fees-regulations-1995",
  "path": "schedule/1/paragraph/5",
  "kind": "paragraph",
  "number": "5",
  "heading": "Marketing authorisations and product licences",
  "text": "(1) Subject to sub-paragraphs (2) and (3), where an application for a marketing authorisation or product licence consists of an application for more than one such authorisation or licence each relating to a product containing the same active ingredient or combination of ingredients, the fee shall be of an amount equal to the aggregate of the amounts payable under paragraph 1 in respect of separate applications for each such authorisation or licence.\n(2) If the application is a major application, the fee shall be the amount payable in respect of a major application under paragraph 1 plus—\n(a) in respect of each additional marketing authorisation or product licence applied for which relates to a product of a different dosage form, the amount payable in respect of a complex application under paragraph 1; and\n(b) in respect of each additional marketing authorisation or product licence applied for which relates to a product of the same dosage form but of a different strength of active ingredient or different combination of active ingredients, the amount payable in respect of a standard application under paragraph 1.\n(3) If the application is a complex application, the amount payable shall be the amount payable in respect of a complex application under paragraph 1 plus—\n(a) in respect of each additional marketing authorisation or product licence applied for which relates to a product of a different dosage form, the amount payable in respect of a standard application under paragraph 1; and\n(b) in respect of each additional marketing authorisation or product licence applied for which relates to a product of the same dosage form but of a different strength of active ingredient or different combination of active ingredients, the amount payable in respect of a simple application under paragraph 1.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [
    {
      "type": "added",
      "affecting": "uksi/1996/2196",
      "affecting_title": "The Medicines (Products for Animal Use — Fees) (Amendment) Regulations 1996"
    }
  ],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/1995/2364/schedule/1/paragraph/5",
    "retrieved_at": "2026-10-29T13:02:01.592022+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}